Explore MyBioSource's premium PCR kits for disease detection and genetic research, offering fast, accurate results for oncology, infectious diseases, and more.
The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...
SAN ANTONIO — A new study strengthens the evidence that pathological complete response (pCR) is a good surrogate marker of longer-term efficacy in the neoadjuvant drug treatment of breast cancer. pCR, ...
Traditionally, test developers have used quantitative PCR (qPCR) to create highly specific laboratory-developed tests (LDTs). However, digital PCR (dPCR) is emerging as the preferred technology for ...
The at-home tests are not yet available, but the U.S. Food and Drug Administration approved two self-swab tests from the ...
“Neoadjuvant treatment with 12 weeks of THP led to a pCR rate of 64% in patients with early-stage HER2-positive, ER-negative breast cancer at the time of surgery, compared to 33% for those with ...
PCR-based techniques have transformed how scientists analyze transcripts’ translational applications in cancer and ...
If conducted every year or every other year, the multi-cancer early detection blood test could help more people survive cancer, researchers reported Thursday in BMJ Open. Adobe stock/HealthDay May 9 ...
Hosted on MSN
Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients
Patients with Stage II and III (early-stage) HER2+ breast cancer usually undergo preoperative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback